PuSH - Publikationsserver des Helmholtz Zentrums München


182 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
Ghalandary et al.: WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice. Blood, DOI: 10.1182/blood.2022016411 (2022)
Linder, M.I.* et al.: Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes. Blood, DOI: 10.1182/blood.2022016783 (2022)
Philipp, N.* et al.: T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals. Blood 140, 1104-1118 (2022)
Roas, M.* et al.: Targeting FLT3 by new-generation antibody-drug-conjugate in combination with kinase inhibitors for treatment of AML. Blood, DOI: 10.1182/blood.2021015246 (2022)
Augsberger, C.* et al.: Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC specific T-cell bispecific antibody. Blood 138, 2655-2669 (2021)
Chen, B.R.* et al.: A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis In AF10-rearranged AML. Blood 137, 3403-3415 (2021)
Chen, J.* et al.: ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia. Blood 137, 3629-3640 (2021)
Deng, Y.* et al.: CD27 is required for protective lytic EBV antigen specific CD8+ T cell expansion. Blood 137, 3225-3236 (2021)
Frey, L.* et al.: Mammalian VPS45 orchestrates trafficking through the endosomal system. Blood 137, 1932-1944 (2021)
Hecker, J.S.* et al.: CHIP & HIPs: Clonal hematopoiesis is common in hip arthroplasty patients and associates with autoimmune disease. Blood 138, 1727-1732 (2021)
Matek, C. ; Krappe, S.* ; Münzenmayer, C.* ; Haferlach, T.* & Marr, C.: Highly accurate differentiation of bone marrow cell morphologies using deep neuralnetworks on a large image dataset Blood 138, 1917-1927 (2021)
Sormendi, S.* et al.: HIF2α is a direct regulator of neutrophil motility. Blood 137, 3416-3427 (2021)
Stenger, D.* et al.: Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. Blood 136, 1407-1418 (2020)
Bahrami, E. et al.: A CRISPR/Cas9 library screen in patients’ leukemia cells in vivo. Blood 134, 1:3945 (2019)
Garg, S.* et al.: Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML. Blood 134, 263-276 (2019)
Sperling, S. et al.: Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells. Blood 133, 2597-2609 (2019)
Burchert, A.* et al.: Sorafenib as maintenance therapy post allogeneic stem cell transplantation for FLT3-ITD positive AML: Results from the randomized, double-blind, placebo-controlled multicentre sormain trial. Blood 132 (2018)
Danisch, S.* ; Slabik, C.* ; Zeidler, R. ; Ganser, A.* & Stripecke, R.*: CAR-T cells targeting gp350 recognize immortalized cells latently infected with EBV. Blood 132 (2018)
De Braekeleer, E.* et al.: The nucleotide kinase nadk is required for ROS detoxification and constitutes a metabolic vulnerability of NOTCH1-driven T-ALL. Blood 132 (2018)
Ebinger, S. ; Vick, B. ; Spiekermann, K.* & Jeremias, I.: Long-term dormant cells in acute myeloid leukemia patient-derived xenografts display reversible treatment resistance, but are not enriched for leukemia-initiating cells. Blood 132 (2018)